Valuation: Dr. Martens plc

Market Cap 628M 841M 753M 694M 1.17B 79.84B 1.2B 8.26B 3.31B 41.99B 3.15B 3.09B 132B P/E 2027 *
13.4x
P/E 2028 * 10.7x
Enterprise Value 826M 1.11B 991M 912M 1.54B 105B 1.57B 10.86B 4.35B 55.22B 4.14B 4.06B 174B EV / Sales 2027 *
1.06x
EV / Sales 2028 * 0.98x
Free-Float
57.55%
Yield 2027 *
3.82%
Yield 2028 * 3.86%
1 day-0.15%
1 week-0.46%
Current month-6.42%
1 month-5.20%
3 months-16.11%
6 months+7.54%
Current year-14.36%
1 week 64.1
Extreme 64.1
69.3
1 month 64.1
Extreme 64.1
72
Current year 59.15
Extreme 59.15
90
1 year 59.15
Extreme 59.15
95.55
3 years 43.02
Extreme 43.02
128
5 years 43.02
Extreme 43.02
448.2
10 years 43.02
Extreme 43.02
521.6
Manager TitleAgeSince
Chief Executive Officer 55 05/01/2025
Director of Finance/CFO 53 12/05/2024
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 31/12/2020
Director/Board Member 55 09/07/2025
Director/Board Member 52 31/12/2020
Date Insider Type Main position Quantity % Market Cap. Importance
29/05/26 Free

Chief Executive Officer

2,732,653 0.2823%
29/05/26 Free

Chief Financial Officer

2,100,151 0.2170%
13/05/26 Buy

Chief Financial Officer

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-0.46%-29.46%-42.96% 841M
+0.65%+0.91%-40.83%-60.53% 57.07B
+0.84%+6.01%+2.00%+1.35% 32.47B
+4.88%+0.08%+23.26%+304.77% 19.99B
-0.93%-3.86%-2.21%-14.65% 11.27B
+2.99%-0.65%-14.02%+37.82% 10.96B
+3.87%+18.88%-27.52%-24.18% 6.75B
+0.17%+24.41%+77.73%+75.06% 6.94B
+0.12%-0.74%-16.67%-12.19% 5.94B
+5.59%+6.06%+29.22%-49.72% 4.14B
Average +1.80%+3.20%+0.15%+21.48% 15.64B
Weighted average by Cap. +1.50%+1.78%-10.41%+19.02%

Financials

2027 *2028 *
Net sales 778M 1.04B 934M 860M 1.46B 98.98B 1.48B 10.24B 4.1B 52.05B 3.91B 3.83B 164B 816M 1.09B 979M 902M 1.53B 104B 1.55B 10.74B 4.3B 54.59B 4.1B 4.01B 172B
Net income 48.4M 64.81M 58.07M 53.47M 90.56M 6.15B 92.16M 637M 255M 3.24B 243M 238M 10.21B 59.88M 80.18M 71.83M 66.15M 112M 7.61B 114M 788M 315M 4B 301M 294M 12.63B
Net Debt 198M 265M 237M 219M 370M 25.16B 377M 2.6B 1.04B 13.23B 993M 973M 41.74B 170M 228M 204M 188M 318M 21.62B 324M 2.24B 895M 11.37B 853M 836M 35.87B
Projected Income Statement - Annual - Dr. Martens plc
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Date Price Change Volume
30/10/26 GBX 65.60 -0.15% 792,437
29/10/26 GBX 65.70 -0.45% 513,018
28/10/26 GBX 66.00 +0.15% 547,887
27/10/26 GBX 65.90 +0.15% 701,417
26/10/26 GBX 65.80 +0.30% 822,469
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Dr. Martens plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6560GBP
Average target price
0.9767GBP
Spread / Average Target
+48.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Martens plc
  1. Stock Market
  2. Stocks
  3. DOCS Stock